产品详情 |
Edit |   |
Product Name | Recombinant Human Matrilin-3 Protein, CF |
Description | Purity >95%, by SDS-PAGE under reducing conditions and visualized by silver stain. MW (observed): 57 kDa, reducing conditions. MW (theoretical): 50.6 kDa. The Recombinant Human Matrilin-3 Protein from R&D Systems is derived from NS0. The Recombinant Human Matrilin-3 Protein has been validated for the following applications: Binding Activity. |
Size | 50 ug |
Concentration | n/a |
Applications | Binding Activity |
Other Names | B14.5b, CI-B14.5b, complex I subunit B14.5b, Complex I-B14.5b, EDM5, HLC-1NADH dehydrogenase (ubiquinone) 1, subcomplex unknown, 2 (14.5kD, B14.5b), HOA, Human lung cancer oncogene 1 protein, Matrilin3, NADH dehydrogenase (ubiquinone) 1, subcomplex unknown, 2, 14.5kDa, NADH dehydrogenase [ubiquinone] 1 subunit C2, NADHDH2, NADH-ubiquinone oxidoreductase subunit B14.5b, NDUFC2 |
Gene, Accession, CAS # | NDUFC2, Gene ID: 4148, Accession: O15232 |
Catalog # | 3017-MN-050 |
Price | |
Order / More Info | Recombinant Human Matrilin-3 Protein, CF from R&D SYSTEMS, INC. |
Product Specific References | PubMed: 17311924, 22057346, 25331953 |
产品资料 |
|
|